XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Beginning Balance (in shares) at Sep. 30, 2023   13,950    
Beginning Balance at Sep. 30, 2023 $ 102,439 $ 14 $ 99,974 $ 2,451
Expense related to director restricted stock units 618   618  
Expense related to director restricted stock unit (shares)   0    
Expense related to employee stock-based compensation 1,280   1,280  
Stock issued for director restricted stock units (in shares)   62    
Exercise of stock options (shares)   760    
Exercise of stock options 261   261  
Common shares surrendered for stock option exercises and restricted stock unit vesting (in shares)   (381)    
Common shares surrendered for stock option exercises and restricted stock unit vesting (1,863)   (1,863)  
Net income $ 7,397     7,397
Ending Balance (in shares) at Sep. 30, 2024 14,391 14,391    
Ending Balance at Sep. 30, 2024 $ 110,132 $ 14 100,270 9,848
Expense related to director restricted stock units 618   618  
Expense related to employee stock-based compensation $ 846   846  
Stock issued for director restricted stock units (in shares)   123    
Exercise of stock options (shares) 0      
Common shares surrendered for stock option exercises and restricted stock unit vesting (in shares)   (16)    
Common shares surrendered for stock option exercises and restricted stock unit vesting $ 0   0  
Net income $ 1,362     1,362
Ending Balance (in shares) at Sep. 30, 2025 14,498 14,498    
Ending Balance at Sep. 30, 2025 $ 112,958 $ 14 $ 101,734 $ 11,210